2 completed, 1 recruiting, 1 withdrawn. 4 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 2, Recruiting 1, Withdrawn 1 |
| Phase 2 | 2 | Completed 1, Withdrawn 1 |
Follow Coagulopathy: new trials by email Literature Review of Coagulopathy trials Research Report on Coagulopathy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Learn About How Safe BAY 3389934 is, Its Suitable Dose, and How it Affects the Participants With Sepsis Induced Coagulopathy BAY3389934 - Sepsis, Coagulopathy | Phase 1 | Recruiting | Bayer | 36 | 2025-03-12 | 2026-10-16 |
| Ascending Dose Study of FrontlineODP™ Spray Dried Plasma Autologous Spray Dried Plasma - Coagulopathy, Hemorrhage | Phase 1 | Completed | Velico Medical | 24 | 2022-12-01 | 2025-09-18 |
| The Utility of Camostat Mesylate in Patients With COVID-19 Associated Coagulopathy (CAC) and Cardiovascular Complications Camostat Mesylate, Microcrystalline Cellulose, NF - Coagulopathy, Cardiovascular Complication | Phase 1 / Phase 2 | Withdrawn | Yale University | 2021-11-01 | 2022-05-18 | |
| Fibrinogen in the Initial Resuscitation of Severe Trauma (FiiRST) Fibrinogen concentrate, Placebo Comparator - Trauma, Injury | Phase 1 / Phase 2 | Completed | Sunnybrook Health Sciences Centre | 50 | 2014-10-01 | 2016-04-14 |
Hemostatic Disorders (4) · Hemorrhage (2) · Afibrinogenemia (1) · COVID-19 (1) · Disseminated Intravascular Coagulation (1) · Sepsis (1) · Wounds and Injuries (1)
Cardiovascular Diseases (4) · Hematologic Diseases (4) · Hemic and Lymphatic Diseases (4) · Hemorrhagic Disorders (4) · Vascular Diseases (4) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Blood Coagulation Disorders (2) · Infections (2) · Blood Coagulation Disorders, Inherited (1) · Coagulation Protein Disorders (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Coronaviridae Infections (1) · Coronavirus Infections (1) · Genetic Diseases, Inborn (1)
Fibrinogen (1) · Saline Solution (1) · camostat (1) · microcrystalline cellulose (1)
Bayer (1) · Sunnybrook Health Sciences Centre (1) · Velico Medical (1) · Yale University (1)
United States (2) · Belgium (1) · Canada (1) · France (1) · Germany (1) · Netherlands (1)
Arya Mani, MD (1) · Barto Nascimento, MD MSc (1) · Mark Popovsky, MD (1)